Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Adipokines, Inflammation, and Metabolic Diseases, Adipose Tissue and Metabolism, Lipid metabolism and disorders, and SARS-CoV-2 and COVID-19 Research.
Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2
Extreme Temperatures and Stroke Mortality: Evidence From a Multi-Country Analysis
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia
Studying severe long COVID to understand post-infectious disorders beyond COVID-19
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency
Salivary Biomarkers as Predictors of Obesity and Intermediate Hyperglycemia in Adolescents
Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
Development of a clinical risk score to predict death in patients with COVID‐19
Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells
Clinical characteristics and outcomes of COVID-19 patients with diabetes mellitus in Kuwait
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Neutral sphingomyelinase 2 regulates inflammatory responses in monocytes/macrophages induced by TNF-α
Clinical Characteristics and Outcomes of COVID-19 patients with diabetes mellitus in Kuwait
Identification and management of Lynch syndrome in the Middle East and North African countries: outcome of a survey in 12 countries
The spectrum of <i>BRCA1</i> and <i>BRCA2</i> pathogenic sequence variants in Middle Eastern, North African, and South European countries
Pathogenic Germline Variants in 10,389 Adult Cancers
Genetic Testing and Clinical Management Practices for Variants in Non-<i>BRCA1</i>/<i>2</i> Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group
Discovery and clinical introduction of first-in-class imipridone ONC201
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
Global implementation of genomic medicine: We are not alone
Causes of genome instability: the effect of low dose chemical exposures in modern society
The effect of environmental chemicals on the tumor microenvironment
Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression
The population genomic landscape of human genetic structure, admixture history and local adaptation in Peninsular Malaysia